Cargando…

Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study

FDG-PET/MR is a hybrid imaging modality used for the staging and restaging of advanced head & neck cancer (HNC) patients. Their treatment typically involves radiation therapy, which requires previous dental focus assessment. The aim of this study was to analyze if staging FDG-PET/MR is a valuabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdec, Silvio, Bosshard, Fabienne A., Hüllner, Martin, Schwaninger, Dominic R., Stocker, Larissa, Giacomelli-Hiestand, Barbara, Stadlinger, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977518/
https://www.ncbi.nlm.nih.gov/pubmed/35386916
http://dx.doi.org/10.3389/fmed.2022.809323
_version_ 1784680782015496192
author Valdec, Silvio
Bosshard, Fabienne A.
Hüllner, Martin
Schwaninger, Dominic R.
Stocker, Larissa
Giacomelli-Hiestand, Barbara
Stadlinger, Bernd
author_facet Valdec, Silvio
Bosshard, Fabienne A.
Hüllner, Martin
Schwaninger, Dominic R.
Stocker, Larissa
Giacomelli-Hiestand, Barbara
Stadlinger, Bernd
author_sort Valdec, Silvio
collection PubMed
description FDG-PET/MR is a hybrid imaging modality used for the staging and restaging of advanced head & neck cancer (HNC) patients. Their treatment typically involves radiation therapy, which requires previous dental focus assessment. The aim of this study was to analyze if staging FDG-PET/MR is a valuable tool for oral focus assessment. For this purpose, FDG-PET/MR findings, such as metabolic activity of periapical radiolucencies and marginal periodontitis, were retrospectively compared with conventional standardized dental focus assessment, including dental radiographs and clinical assessment of 124 teeth in seven patients. Increased FDG uptake of periapical lesions was found in one out of 23 lesions. Increased FDG uptake of the marginal periodontium was recorded in one out of 34 lesions. In summary, standardized dental focus assessment by panoramic radiography and periapical radiographs may be enriched by information from FDG-PET/MR, showing active inflammation in dental foci. However, many dental foci have no correlate in FDG-PET/MR. The treatment decision for oral foci may benefit from the visualized presence or absence of metabolic activity on FDG-PET/MR.
format Online
Article
Text
id pubmed-8977518
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89775182022-04-05 Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study Valdec, Silvio Bosshard, Fabienne A. Hüllner, Martin Schwaninger, Dominic R. Stocker, Larissa Giacomelli-Hiestand, Barbara Stadlinger, Bernd Front Med (Lausanne) Medicine FDG-PET/MR is a hybrid imaging modality used for the staging and restaging of advanced head & neck cancer (HNC) patients. Their treatment typically involves radiation therapy, which requires previous dental focus assessment. The aim of this study was to analyze if staging FDG-PET/MR is a valuable tool for oral focus assessment. For this purpose, FDG-PET/MR findings, such as metabolic activity of periapical radiolucencies and marginal periodontitis, were retrospectively compared with conventional standardized dental focus assessment, including dental radiographs and clinical assessment of 124 teeth in seven patients. Increased FDG uptake of periapical lesions was found in one out of 23 lesions. Increased FDG uptake of the marginal periodontium was recorded in one out of 34 lesions. In summary, standardized dental focus assessment by panoramic radiography and periapical radiographs may be enriched by information from FDG-PET/MR, showing active inflammation in dental foci. However, many dental foci have no correlate in FDG-PET/MR. The treatment decision for oral foci may benefit from the visualized presence or absence of metabolic activity on FDG-PET/MR. Frontiers Media S.A. 2022-03-21 /pmc/articles/PMC8977518/ /pubmed/35386916 http://dx.doi.org/10.3389/fmed.2022.809323 Text en Copyright © 2022 Valdec, Bosshard, Hüllner, Schwaninger, Stocker, Giacomelli-Hiestand and Stadlinger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Valdec, Silvio
Bosshard, Fabienne A.
Hüllner, Martin
Schwaninger, Dominic R.
Stocker, Larissa
Giacomelli-Hiestand, Barbara
Stadlinger, Bernd
Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
title Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
title_full Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
title_fullStr Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
title_full_unstemmed Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
title_short Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients—A Feasibility Study
title_sort value of fdg-pet/mr in oral focus assessment in head and neck cancer patients—a feasibility study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977518/
https://www.ncbi.nlm.nih.gov/pubmed/35386916
http://dx.doi.org/10.3389/fmed.2022.809323
work_keys_str_mv AT valdecsilvio valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy
AT bosshardfabiennea valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy
AT hullnermartin valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy
AT schwaningerdominicr valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy
AT stockerlarissa valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy
AT giacomellihiestandbarbara valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy
AT stadlingerbernd valueoffdgpetmrinoralfocusassessmentinheadandneckcancerpatientsafeasibilitystudy